| HaCaT 각질형성세포에서 interferon-gamma 에 의해 유도된 MDC 와 STATl
signaling pathway 에 대한 rengyolone 의 억제 효과 |
|
강나진, 강경진, 한상철, 강희경, 유은숙 |
|
제주대학교 의학전문대학원 약리학교실 |
| Rengyolone inhibits MDC/CCL22 expression and STAT1 signaling pathway induced by interferon-y in HaCaT keratinocyte |
|
Na-Jin Kang, Gyeoung-Jin Kang, Sang-Chul Han, Hee-Kyoung Kang, Eun-Sook Yoo |
|
Department of Pharmacology, Jeju National University School of Medicine, Jeju, Korea |
Correspondence:
Eun-Sook Yoo, Email: eunsyoo@jejunu.ac.kr
|
|
|
| Abstract |
|
Rengyolone is a cyclohexylethanoid isolated from the Eurya emarginate (Thunb) Makino. lt has been shown to exhibit antibacterial activity, anti-inflammatory, and diuretic. The aim of this study was to investigate the effective and activated mechanism by which rengyolone inhibits IFN-γ-induced MDC expression in the human keratinocyte cell line HaCaT. We found that rengyolone dose dependently inhibited MDC production by lFN-γ stimulation in HacaT keratinocytes. Also rengyolone suppressed IFN-γ-induced phosphorylation of STAT1, a key transcription factor infiltrating IFN-γ signaling pathway. Therefore We propose that Rengyolone could be used as a basis therapeutic material against atopic dermatitis. |
| Key Words:
rengyolone; HaGaT; MDC; interferon-y; STAT1 |
|
PDF Links
Full text via DOI
Download Citation
